61 related articles for article (PubMed ID: 25550600)
1. Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial.
De Sanctis R; Bertuzzi A; Basso U; Comandone A; Marchetti S; Marrari A; Colombo P; Lutman RF; Giordano L; Santoro A
Anticancer Res; 2015 Jan; 35(1):543-7. PubMed ID: 25550600
[TBL] [Abstract][Full Text] [Related]
2. Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.
Buonadonna A; Scalone S; Lombardi D; Fumagalli A; Guglielmi A; Lestuzzi C; Polesel J; Canzonieri V; Lamon S; Giovanis P; Gagno S; Corona G; Mascarin M; Belluco C; De Paoli A; Fasola G; Puglisi F; Miolo G
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894403
[TBL] [Abstract][Full Text] [Related]
3. Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma.
Van Tine BA; Hirbe AC; Oppelt P; Frith AE; Rathore R; Mitchell JD; Wan F; Berry S; Landeau M; Heberton GA; Gorcsan J; Huntjens PR; Soyama Y; Vader JM; Alvarez-Cardona JA; Zhang KW; Lenihan DJ; Krone RJ
Clin Cancer Res; 2021 Jul; 27(14):3854-3860. PubMed ID: 33766818
[TBL] [Abstract][Full Text] [Related]
4. A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma.
Ramaswami R; Uldrick TS; Polizzotto MN; Wyvill KM; Goncalves P; Widell A; Lurain K; Steinberg SM; Figg WD; Tosato G; Whitby D; Yarchoan R
Clin Cancer Res; 2019 Jul; 25(14):4238-4247. PubMed ID: 30979736
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials.
Wang BC; Kuang BH; Xiao BY; Lin GH
Front Oncol; 2021; 11():762288. PubMed ID: 34881180
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Morbidity and Mortality in Patients with Sarcoma: A Population-Based Study.
Alanazi R; Aljizeeri A; Alsaileek A; Alrashid A; Alolayan A; Alkaiyat M; Alenazy B; Shehata H; Alqahtani J; Ardah H; Alshammari K
Clin Med Insights Oncol; 2024; 18():11795549241237703. PubMed ID: 38558879
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma.
Katz D; Boonsirikamchai P; Choi H; Lazar AJ; Wang WL; Xiao L; Park MS; Ravi V; Benjamin RS; Araujo DM
Clin Sarcoma Res; 2012 Jan; 2(1):2. PubMed ID: 22587772
[TBL] [Abstract][Full Text] [Related]
8. DNA-Dependent Protein Kinase Inhibitor Peposertib Potentiates the Cytotoxicity of Topoisomerase II Inhibitors in Synovial Sarcoma Models.
Revia S; Budzinska MA; Bogatyrova O; Neumann F; Zimmermann A; Amendt C; Albers J
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201616
[TBL] [Abstract][Full Text] [Related]
9. Local Immunoradiotherapy in Patients With Metastatic Soft-Tissue Sarcoma.
Levy A; Deutsch E; Le Péchoux C
JAMA Oncol; 2024 Apr; ():. PubMed ID: 38602668
[No Abstract] [Full Text] [Related]
10. Local Immunoradiotherapy in Patients With Metastatic Soft-Tissue Sarcoma-Reply.
Seo YD; Pollack SM
JAMA Oncol; 2024 Apr; ():. PubMed ID: 38602667
[No Abstract] [Full Text] [Related]
11. Combination of trabectedin and gemcitabine for advanced soft tissue sarcomas: results of a phase I dose escalating trial of the German Interdisciplinary Sarcoma Group (GISG).
Kasper B; Reichardt P; Pink D; Sommer M; Mathew M; Rauch G; Hohenberger P
Mar Drugs; 2015 Jan; 13(1):379-88. PubMed ID: 25591040
[TBL] [Abstract][Full Text] [Related]
12. The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities.
Nakano K; Motoi N; Takahashi S
Intern Med; 2015; 54(2):187-93. PubMed ID: 25743010
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for soft-tissue sarcomas.
Ravi V; Patel S; Benjamin RS
Oncology (Williston Park); 2015 Jan; 29(1):43-50. PubMed ID: 25592207
[TBL] [Abstract][Full Text] [Related]
14. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
[TBL] [Abstract][Full Text] [Related]
15. Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets.
Movva S; Wen W; Chen W; Millis SZ; Gatalica Z; Reddy S; von Mehren M; Van Tine BA
Oncotarget; 2015 May; 6(14):12234-47. PubMed ID: 25906748
[TBL] [Abstract][Full Text] [Related]
16. Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial.
Blay JY; Pápai Z; Tolcher AW; Italiano A; Cupissol D; López-Pousa A; Chawla SP; Bompas E; Babovic N; Penel N; Isambert N; Staddon AP; Saâda-Bouzid E; Santoro A; Franke FA; Cohen P; Le-Guennec S; Demetri GD
Lancet Oncol; 2015 May; 16(5):531-40. PubMed ID: 25864104
[TBL] [Abstract][Full Text] [Related]
17. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.
Kawai A; Araki N; Sugiura H; Ueda T; Yonemoto T; Takahashi M; Morioka H; Hiraga H; Hiruma T; Kunisada T; Matsumine A; Tanase T; Hasegawa T; Takahashi S
Lancet Oncol; 2015 Apr; 16(4):406-16. PubMed ID: 25795406
[TBL] [Abstract][Full Text] [Related]
18. Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study.
Diéras V; Wildiers H; Jassem J; Dirix LY; Guastalla JP; Bono P; Hurvitz SA; Gonçalves A; Romieu G; Limentani SA; Jerusalem G; Lakshmaiah KC; Roché H; Sánchez-Rovira P; Pienkowski T; Seguí Palmer MÁ; Li A; Sun YN; Pickett CA; Slamon DJ
Breast; 2015 Jun; 24(3):182-90. PubMed ID: 25747197
[TBL] [Abstract][Full Text] [Related]
19. Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group.
Le Cesne A; Ray-Coquard I; Duffaud F; Chevreau C; Penel N; Bui Nguyen B; Piperno-Neumann S; Delcambre C; Rios M; Chaigneau L; Le Maignan C; Guillemet C; Bertucci F; Bompas E; Linassier C; Olivier T; Kurtz JE; Even C; Cousin P; Yves Blay J;
Eur J Cancer; 2015 Apr; 51(6):742-50. PubMed ID: 25727882
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
